Posted by Michael Wonder on 15 Nov 2022
ATAGI recommendations on use of the Pfizer COVID-19 vaccine for children aged 6 months to 4 years
15 November 2022 - On 29 September 2022, the TGA provisionally approved Comirnaty (Pfizer) COVID-19 vaccine for use in children aged 6 months to 4 years.
The ATAGI has evaluated data on immunogenicity, efficacy, and safety to consider the use of the Pfizer 6 months to 4 years COVID-19 vaccine in this age group.
